fashion -WSS

fashion

author：explore 2025-09-27 12:58:15 - browse：111

A product image of the Cue reader COVID-19 home use test — Businesswire via AP

The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19 tests. This follows an FDA warning letter to the company last week that said Cue was not following the conditions stipulated in the emergency use authorizations for its tests.

The FDA letters said the tests could give false results. Specifically, the agency said that the company had changed how the electrochemical signals within the test device were generated, received, and interpreted — changes the FDA has not authorized. These changes decreased the stability of the tests and might lead to false results, the agency said.

The FDA warnings come near what might be the end of a spectacularly bumpy ride for the company. When Cue went public in 2021, it was valued at nearly $3 billion. It supplied tests for the NBA’s 2020 “bubble,” leading a Trump administration official to proclaim that if the test was “good enough for LeBron,” the administration would bring it to the American people — and it did, in a $481 million deal.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Are infertility treatments 'essential' during the Covid

hotspot

WSS

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Childhood cancer progress stalls for Black, Hispanic kids: Report

Sanders wants to replace patents with prizes for drug inventions

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Weight loss drug costs may need more research, senator suggests

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Cancer drug shortages should be causing more outrage

Scientists grapple with ethics of stem cell research

What does generative AI mean for health care? We asked experts

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Sports medicine is finally prioritizing gender equality

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Duchenne breakthrough therapy leaves behind pioneering families

A daunting task: navigating dual Medicare, Medicaid eligibility

Medicare proposal to cover medical devices draws a mixed reaction

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

knowledge

Morphosys mixed study results for blood cancer drug

Gain of function research would be limited under House proposal

NYU radiologists take on the challenge of expensive MRI machines

US jobless claims fall again as labor market continues to flash strength

Sanders wants to replace patents with prizes for drug inventions

World's first CRISPR

focus

Wikipedia

hotspot

hotspot